研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

JARID2 是一种新型调节因子,可促进口腔鳞状细胞癌的细胞增殖、迁移和侵袭。

JARID2, a novel regulatory factor, promotes cell proliferation, migration, and invasion in oral squamous cell carcinoma.

发表日期:2024 Jul 03
作者: Yuxi Cheng, Zhengzheng Song, Jingyi Cheng, Zhangui Tang
来源: Cellular & Molecular Immunology

摘要:

基因表达的精确调控对于细胞的正常发育和功能至关重要。相关基因JARID2在OSCC中的预后意义和潜在致癌机制尚不清楚,但现有研究表明两者之间存在显着关联。 OSCC患者肿瘤样本中JARID2基因的表达与临床病理因素的关系使用免疫组织化学实验和 RT-qPCR 分析进行分析。根据患者的临床病理数据,利用公共数据库进行生物信息学分析,以确定JARID2在OSCC中的功能。构建了敲除的 OSCC 细胞系,并通过 CCK-8、伤口愈合实验和 Transwell 分析评估了 JARID2 对 OSCC 细胞系生物学行为的影响。免疫组化实验证实了 JARID2 与 OSCC 患者预后的相关性,同时RT-qPCR 实验证明了其在组织和细胞中的表达水平。 CKK-8实验、伤口愈合实验和Transwell实验表明,敲除JARID2对OSCC细胞的增殖、侵袭和迁移产生负面影响。生物信息学分析结果表明,JARID2在OSCC中的表达与患者基因共表达、基因功能富集、免疫浸润和药物敏感性密切相关。我们的研究表明JARID2是OSCC的一种新型预后生物标志物和潜在的治疗靶点。© 2024。作者。
Accurate regulation of gene expression is crucial for normal development and function of cells. The prognostic significance and potential carcinogenic mechanisms of the related gene JARID2 in OSCC are not yet clear, but existing research has indicated a significant association between the two.The relationship between the expression of the JARID2 gene in tumor samples of OSCC patients and clinical pathological factors was analyzed using immunohistochemistry experiments and RT-qPCR analysis. Based on the clinical pathological data of patients, bioinformatics analysis was conducted using public databases to determine the function of JARID2 in OSCC. Knockdown OSCC cell lines were constructed, and the impact of JARID2 on the biological behavior of OSCC cell lines was assessed through CCK-8, wound healing assay, and transwell analysis.Immunohistochemistry experiments confirmed the correlation between JARID2 and the prognosis of OSCC patients, while RT-qPCR experiments demonstrated its expression levels in tissue and cells. CKK-8 experiments, wound healing assays, and Transwell experiments indicated that knocking down JARID2 had a negative impact on the proliferation, invasion, and migration of OSCC cells. Bioinformatics analysis results showed that the expression of JARID2 in OSCC is closely associated with patient gene co-expression, gene function enrichment, immune infiltration, and drug sensitivity.Our study indicates that JARID2 is a novel prognostic biomarker and potential therapeutic target for OSCC.© 2024. The Author(s).